Haploidentical Transplant in China
For patients without a fully matched donor, haploidentical stem cell transplantation — using a half-matched parent, sibling, or child as donor — is an established option with documented clinical experience at specialised Chinese haematology centres. The Beijing Protocol, developed at Peking University Institute of Hematology, has been validated in published international studies and is used as a reference approach at multiple transplant centres in China.
Quick Answer
Haploidentical (half-matched) transplant uses a parent, sibling, or child as donor when a fully matched unrelated donor is not available. China's Beijing Protocol is an internationally validated approach with published outcomes. International families can request structured expert case review remotely before deciding whether to travel to China for transplant.
Key Topics Covered
Articles & Guides
No Full Match Donor for AML Bone Marrow Transplant: What Are the Options?
Can a Child Receive a Second Bone Marrow Transplant?
What Are the Options When No Matched Unrelated Donor Is Available?
What Families Should Know Before Pediatric Bone Marrow Transplantation
What 22,381 Pediatric Transplants Reveal About HCT Practice in China: CCBMTR 2017–2024
Beijing Protocol: Haploidentical Stem Cell Transplant — Evidence for International Patients
Blood Cancer Treatments Beyond Chemotherapy and CAR-T
Additional articles on haploidentical transplant for specific conditions are being prepared. Check back or contact us to request specific topics.
Related Services & Areas
Haploidentical Transplant Coordination Service
Our coordination service for patients considering haplo-HSCT in China
Online MDT Second Opinion
Request a structured expert review before any transplant decision
Pediatric Leukemia & Blood Disorders
For families facing pediatric leukemia and complex transplant decisions
CAR-T & Cell Therapy
For patients exploring CAR-T therapy as an alternative or bridge to transplant
Request a Structured Transplant Case Review
If donor shortage, transplant eligibility, or relapse after transplant is a concern for your family, a structured case review can help clarify whether haploidentical transplant in China may be relevant.